Horizon Pharma Sees Mid-2019 BLA For Tepro After Solid Phase III TED Data

 
• By Sten Stovall
Eye
OPTIC Phase III Study Was In thyroid eye disease (TED) • Source: Shutterstock

More from Sensory

More from Therapeutic Category